作为一种新型的超短效苯二氮卓类药物,瑞马唑仑起效迅速,代谢不依赖肝、肾功能,对呼吸和循环的抑制作用小,且具备特异性拮抗药物氟马西尼。相关临床研究证明瑞马唑仑在全身麻醉诱导和维持方面具备广阔的临床应用前景。但是,其有效性及安全性需要进一步的临床研究来证实。
As a new type of ultra-short-acting benzodiazepine, remimazolam has rapid onset of action, inde-pendent of liver and kidney function, little inhibitory of respiration and circulation, and has a spe-cific antagonist, flumazenil. Relevant clinical studies have proved that remimazolam has a broad clinical application prospect in induction and maintenance of general anesthesia. However, further clinical studies are required to confirm its efficacy and safety.
瑞马唑仑,全身麻醉诱导与维持, Remimazolam Induction and Maintenance of General Anesthesia摘要
As a new type of ultra-short-acting benzodiazepine, remimazolam has rapid onset of action, independent of liver and kidney function, little inhibitory of respiration and circulation, and has a specific antagonist, flumazenil. Relevant clinical studies have proved that remimazolam has a broad clinical application prospect in induction and maintenance of general anesthesia. However, further clinical studies are required to confirm its efficacy and safety.
Keywords:Remimazolam, Induction and Maintenance of General Anesthesia
闫锦威,吴馨婷,杨靖梅,王学军. 瑞马唑仑用于全身麻醉诱导与维持的研究进展Research Progress of Remimazolam in Induction and Maintenance of General An-esthesia[J]. 临床医学进展, 2022, 12(06): 5245-5249. https://doi.org/10.12677/ACM.2022.126759
参考文献ReferencesJacob, T.C., Moss, S.J. and Jurd, R. (2008) GABAA Receptor Trafficking and Its Role in the Dynamic Modulation of Neuronal Inhibition. Nature Reviews Neuroscience, 9, 331-343. <br>https://doi.org/10.1038/nrn2370Kilpatrick, G.J. (2021) Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. Frontiers in Pharma-cology, 12, Article ID: 690875. <br>https://doi.org/10.3389/fphar.2021.690875Pesic, M., Stöhr, T., Ossig, J., et al. (2020) Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or without Alcohol: Results from Two Randomised Clinical Trials. Drugs in R & D, 20, 267-277. <br>https://doi.org/10.1007/s40268-020-00317-0Pesic, M., Schippers, F., Saunders, R., et al. (2020) Pharmaco-kinetics and Pharmacodynamics of Intranasal Remimazolam—A Randomized Controlled Clinical Trial. European Jour-nal of Clinical Pharmacology, 76, 1505-1516.Antonik, L.J., Goldwater, D.R., Kilpatrick, G.J., et al. (2012) A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics. Anesthesia & Analgesia, 115, 274-283.
<br>https://doi.org/10.1213/ANE.0b013e31823f0c28Wiltshire, H.R., Kilpatrick, G.J., Tilbrook, G.S., et al. (2012) A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part II. Population Pharmacokinetic and Pharmacodynamic Mod-eling and Simulation. Anesthesia & Analgesia, 115, 284-296. <br>https://doi.org/10.1213/ANE.0b013e318241f68aSchüttler, J., Eisenried, A., Lerch, M., et al. (2020) Phar-macokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volun-teers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Anesthesiology, 132, 636-651.Eisenried, A., Schüttler, J., Lerch, M., et al. (2020) Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Con-tinuous Infusion in Healthy Male Volunteers: Part II. Pharmacodynamics of Electroencephalogram Effects. Anesthesiol-ogy, 132, 652-666. <br>https://doi.org/10.1097/ALN.0000000000003102Sthr, T., Colin, P.J., Ossig, J., et al. (2021) Pharmacokinetic Properties of Remimazolam in Subjects with Hepatic or Renal Impairment. BJA British Journal of Anaesthesia, 127, 415-423. <br>https://doi.org/10.1016/j.bja.2021.05.027Zhou, J., Leonowens, C., Ivaturi, V.D., et al. (2020) Population Pharmacokinetic/Pharmacodynamic Modeling for Remimazolam in the Induction and Maintenance of General Anesthesia in Healthy Subjects and in Surgical Subjects. Journal of Clinical Anesthesia, 66, 109899.Zhou, Y., Hu, P. and Jiang, J. (2017) Metabolite Characterization of a Novel Sedative Drug, Remimazo-lam in Human Plasma and Urine Using Ultra High-Performance Liquid Chromatography Coupled with Synapt High-Definition Mass Spectrometry. Journal of Pharmaceutical & Biomedical Analysis, 137, 78-83.
<br>https://doi.org/10.1016/j.jpba.2017.01.016Morita, K., Takeda, J., Sakamoto, A., et al. (2020) Efficacy and Safety of Remimazolam versus Propofol for General Anesthesia: A Multicenter, Single-Blind, Randomized, Paral-lel-Group, Phase IIb/III Trial. Journal of Anesthesia, 34, 543-553. <br>https://doi.org/10.1007/s00540-020-02788-6Hirata, N., Suzuki, T., Morisaki, H., et al. (2020) Safety and Ef-ficacy of Remimazolam in Induction and Maintenance of General Anesthesia in High-Risk Surgical Patients (ASA Class III): Results of a Multicenter, Randomized, Double-Blind, Parallel-Group Comparative Trial. Journal of Anesthesia, 34, 491-501.
<br>https://doi.org/10.1007/s00540-020-02776-wKilpatrick, G.J., Mcintyre, M.S., Cox, R.F., et al. (2007) CNS 7056: A Novel Ultra-Short-Acting Benzodiazepine. Anesthesiology, 107, 60-66.Chen, X., Sang, N., Song, K., et al. (2020) Psychomotor Recovery Following Remimazolam-Induced Sedation and the Effectiveness of Flumazenil as an Antidote. Clinical Therapeutics, 42, 614-624.
<br>https://doi.org/10.1016/j.clinthera.2020.02.006Worthington, M.T., Antonik, L.J., Goldwater, D.R., et al. (2013) A Phase Ib, Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy. Anesthesia & Analgesia, 117, 1093-1100.
<br>https://doi.org/10.1213/ANE.0b013e3182a705aeYoshida, A., Kurata, S., Kida, K., et al. (2021) Anesthetic Management for the Sleep-Awake-Sleep Technique of Awake Craniotomy Using a Novel Benzodiazepine Remimazolam and Its Antagonist Flumazenil. JA Clinical Reports, 7, Article No. 14. <br>https://doi.org/10.1186/s40981-021-00417-zMasui, K. (2020) Remimazolam Besilate, a Benzodiazepine, Has Been Approved for General Anesthesia!! Journal of Anesthesia, 34, 479-482. <br>https://doi.org/10.1007/s00540-020-02755-1Wesolowski, A.M., Zaccagnino, M.P., Malapero, R.J., et al. (2016) Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology. Pharmacotherapy: The Jour-nal of Human Pharmacology and Drug Therapy, 36, 1021-1027. <br>https://doi.org/10.1002/phar.1806Hu, K., Xiang, Q., Wang, Z., et al. (2020) Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxi-doreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese Volunteers. Clinical Pharmacology in Drug Development, 10, 22-29.